ASH Clinical News FINAL_ACN_3.14_FULL_ISSUE_DIGITAL | Page 11
VOLUME 03 | NUMBER 14 | DECEMBER 2017
Around the Network
AMERICAN SOCIETY OF HEMATOLOGY (ASH)
HEADQUARTERS
2021 L Street NW, Suite 900
Washington, DC 20036
www.hematology.org
Tel: 202-776-0544
IN THIS ISSUE
feature
High Hopes
EDITOR-IN-CHIEF
Mikkael Sekeres, MD, MS
Hematology patients are turning to cannabis for symptom
relief, but should they?
Vice-Chair for Clinical Research
Director, Leukemia Program
Cleveland Clinic, Taussig Cancer Institute
Cleveland, OH
109
feature
A World of Difference
ASSOCIATE EDITORS
Beth Faiman, CNP, PhD
A look at the slow march to bring high-quality hematology
and oncology care to limited-resource areas.
Cleveland Clinic
Cleveland, OH
118
Alice Ma, MD
University of North Carolina School of Medicine
Chapel Hill, NC
clinical news
David Steensma, MD
Dana-Farber Cancer Institute
Boston, MA
Keith Stewart, MBChB, MBA
Mayo Clinic
Scottsdale, AZ
PUBLISHER
American Medical Communications (AMC)
EDITORIAL
MANAGING EDITORS
Kristin Hubing, ASH
Ariel Jones-DeMaio, AMC
ASSOCIATE MANAGING EDITOR
Kerri Fitzgerald, AMC
EDITORIAL ASSOCIATE
Laurie Adamson, ASH
ART DIRECTOR
Ari Mihos
ASSISTANT ART DIRECTORS
Charlene DePrizio
John Salesi
DIGITAL PROJECTS MANAGER
Chris Gedikli
ADVERTISING
ACCOUNT MANAGERS
Nick Luciano
[email protected]
Gene Conselyea
[email protected]
Sima Sherman
[email protected]
Recruitment advertising orders can be sent to:
DIRECTOR, RECRUITMENT CLASSIFIEDS
Lauren Morgan
[email protected]
Visit us at ashclinicalnews.org
Follow us on Twitter @ASHClinicalNews
©2017 by the American Society of Hematology.
All materials contained in this newsletter are protected by
copyright laws and may not be used, reproduced, or oth-
erwise exploited in any manner without the express prior
written permission of ASH Clinical News. Any third-party
materials communicated to ASH Clinical News become
its copyrighted property and may be used, reproduced, or
otherwise exploited by ASH Clinical News.
ASHClinicalNews.org
44 E
xamining Infection Risks of Anti-CD19
Gun Violence: A
Public Health Crisis
Does the oath to “do no harm” conflict with the right to bear
arms? Physicians weigh in on the gun control debate.
CAR T-Cell Therapies
58 Higher Cancer Risk Among Patients
With Pregnancy-Related Venous
Thromboembolism
83 On Location: 2017 ASH Annual Meeting
Inside Look
113
ASHCLINICALNEWS.ORG @ASHCLINICALNEWS
With nearly 5,000 abstracts and more
than 150 sessions, the 59th ASH Annual
Meeting & Exposition is jam-packed
with practice-changing science,
educational activities, and networking
opportunities. Follow us on Twitter for
on-site updates from the
annual meeting:
@ASHClinicalNews.
Can’t make it to every session? ASH
Clinical News will be your eyes and ears!
Check our “On Location” section for daily
updates from the meeting:
ashclinicalnews.org/on-location.
Sign up to receive our
e-newsletters to have news
from the annual meeting
delivered to your inbox:
ashclinicalnews.org/
enewsletter-sign-up.
Watch our exclusive interviews with presenters and experts in our “Multimedia”
section: ashclinicalnews.org/multimedia/exclusive-videos.
“YOU MAKE THE CALL” WINNER
Announcing last month’s “You Make the Call: Readers’ Response” winner:
Nalini Janakiraman, MD
Hope you enjoy your prize!
Subscription inquiries should be sent to: [email protected]
All correspondence for the American Society of Hematology should be sent to: American Society of Hematology, 2021 L Street NW, Suite 900, Washington DC 20036.
Neither the American Society of Hematology nor the publisher is responsible for statements made by any editor or contributor. Statements, editorials, or opinions
expressed in ASH Clinical News magazine do not necessarily represent official policy of the American Society of Hematology unless so stated. No responsibility is as-
sumed by the American Society of Hematology or the Publisher for any injury or damage to persons or property as a matter of product liability, negligence or otherwise
or from any use or operation of any methods, products, instructions or ideas contained in the material herein.
Although all advertising material published in ASH Clinical News magazine is expected to conform to ethical (medical) standards, inclusion in this publication does
not constitute a guarantee or endorsement by the American Society of Hematology or the Publisher of the quality or value of such product or of the claim made of it by
its manufacturer.
About the American Society of Hematology
The American Society of Hematology (ASH) is the world’s largest professional society concerned with the causes and treatments of blood disorders. The mission of
the Society is to further the understanding, diagnosis, treatment, and prevention of disorders affecting the blood, bone marrow, and the immunologic, hemostatic
and vascular systems, by promoting research, clinical care, education, training, and advocacy in hematology.
ASH Clinical News (ISSN 2375-8120) is published once per month by American Medical Communications, 630 Madison Avenue, 2nd Floor, Manalapan, NJ 07726.
Periodicals postage is pending/paid at Manalapan, NJ and additional mailing offices. POSTMASTER: Send address changes to American Medical Communications,
630 Madison Avenue, 2nd Floor, Manalapan, NJ 07726. ©Copyright, 2017.
ASH Clinical News
9